Applied DNA Sciences (APDN) Misses Q1 EPS by 36c

Applied DNA Sciences (NASDAQ: APDN) reported Q1 EPS of ($0.63), $0.36 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $4.2 million versus the consensus estimate of $4.02 million.

For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Raymond James Reiterates Underperform Rating on Lennar (LEN)
• CMS targets 15% Medicare lab fee cuts, putting DGX and LH revenue at risk